HAIs (healthcare-associated infections) evolution explains UK C diff (Clostridium difficile) testing focus
This article was originally published in Clinica
Executive Summary
UK efforts to tackle methicillin-resistant Staphylococcus aureus (MRSA) appear to be succeeding in reducing bloodstream healthcare-associated infection (HAI) rates, but a further jump in cases of Clostridium difficile - a non-bloodstream HAI - explains the current drive to further tighten surveillance (see related story).